The Discounted Cash Flow (DCF) valuation of BioCorRx Inc (BICX) is (6.56) USD. With the latest stock price at 0.36 USD, the upside of BioCorRx Inc based on DCF is -1922.5%.
Based on the latest price of 0.36 USD and our DCF valuation, BioCorRx Inc (BICX) is a sell. selling BICX stocks now will result in a potential gain of 1922.5%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.0% - 7.0% | 6.0% |
| Long-term Growth Rate | 3.0% - 4.7% | 3.9% |
| Fair Price | (52.56) - (3.71) | (6.56) |
| Upside | -14700.2% - -1129.5% | -1922.5% |